It is the norm - nothing unusual.
Time and again when the stock is up nicely, there is talk of the company worth 10 to 15 billion dollars; a couple of down days or a really bad day has folks cursing management, shorts, the MMs etc.
A silver lining in the dark clouds is the fact that volume is picking up and even as the company reported a loss of $20.5 million in its fiscal second quarter, I am assuming that they are spending every cent on getting ready to conduct trials and events that add to shareholder value and not for lining their deep deep pockets.
News 
Market Data 
Discover 
